Abbott Medical Devices — Total Assets increased by 2.8% to $10.98B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.5%, from $10.03B to $10.98B.
An increase typically signals capital expansion or investment in new manufacturing capacity and R&D infrastructure, while a decrease may indicate asset divestitures or depreciation outpacing new capital investment.
This metric represents the total economic resources controlled by the medical devices business segment, including proper...
Peers in the medical technology sector typically report similar asset bases, with variations driven by the degree of vertical integration in manufacturing and the scale of investment in proprietary diagnostic and therapeutic hardware.
abt_segment_medical_devices_total_assets| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $7.26B | $7.84B | $9.03B | $9.47B | $10.03B | $10.56B | $10.58B | $10.69B | $10.98B |
| QoQ Change | — | +8.0% | +15.1% | +4.9% | +5.9% | +5.2% | +0.2% | +1.1% | +2.8% |
| YoY Change | — | +8.0% | +15.1% | +4.9% | — | — | — | +12.8% | +9.5% |